Atossa Therapeutics Ownership | Who Owns Atossa Therapeutics?
Atossa Therapeutics Ownership Summary
Atossa Therapeutics is owned by 20.90% institutional investors, 0.06% insiders, and 79.05% retail investors. Blackrock is the largest institutional shareholder, holding 7.34% of ATOS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Atossa Therapeutics shares.
ATOS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Atossa Therapeutics | 20.90% | 0.06% | 79.05% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 3.94M | 3.13% | - |
iShares Russell 2000 ETF | 3.27M | 2.60% | -7.35K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.67M | 1.33% | - |
Fidelity Small Cap Index | 1.30M | 1.04% | -12.51K |
iShares Russell 2000 Value ETF | 1.07M | 0.85% | - |
Fidelity Extended Market Index | 691.60K | 0.55% | -172.00 |
State St Russell Sm Cap® Indx SL Cl I | 578.00K | 0.46% | - |
Vanguard Russell 2000 ETF | 576.47K | 0.46% | -3.60K |
NT R2000 Index Fund - NL | 302.04K | 0.24% | 302.04K |
Schwab Small Cap Index | 301.65K | 0.24% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 10, 2024 | Finn Jonathan | - | Buy | $44.25K |
Nov 15, 2023 | WEAVER GREGORY L | Former EVP, CFO, & Director | Sell | $32.50K |
Jun 20, 2023 | WEAVER GREGORY L | EVP & CFO | Buy | $48.50K |
Jul 02, 2021 | WEAVER GREGORY L | - | Sell | $599.83K |
May 30, 2018 | Chen Shu-Chih | - | Buy | $9.20K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | 1 | - |
2024 Q1 | - | - |
2023 Q4 | - | 1 |
2023 Q2 | 1 | - |
2023 Q1 | - | - |
ATOS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools